BioNeutra Global Corporation
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more
BioNeutra Global Corporation (BGACF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.004x
Based on the latest financial reports, BioNeutra Global Corporation (BGACF) has a cash flow conversion efficiency ratio of -0.004x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($33.44K) by net assets ($-8.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioNeutra Global Corporation - Cash Flow Conversion Efficiency Trend (1997–2023)
This chart illustrates how BioNeutra Global Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioNeutra Global Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioNeutra Global Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Structured Products Corp Corts Tr for Peco Energy Cap Tr III GIC
NYSE:KTH
|
N/A |
|
H&R.BLOCK (HRB.SG)
STU:HRB
|
0.893x |
|
Cann-Is Capital Corp
V:NIS-P
|
0.067x |
|
ANGLO AMERICAN - Dusseldorf Stock Exchang
DU:NGLB
|
N/A |
|
Regent Pacific Properties Inc
V:RPP
|
0.054x |
|
ChemX Materials Ltd
AU:CMX
|
0.416x |
|
General Shopping e Outlets do Brasil S.A.
SA:GSHP3
|
0.029x |
|
Vivid Seats Inc. Warrant
NASDAQ:SEATW
|
0.002x |
Annual Cash Flow Conversion Efficiency for BioNeutra Global Corporation (1997–2023)
The table below shows the annual cash flow conversion efficiency of BioNeutra Global Corporation from 1997 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-6.19 Million | $683.42K | -0.110x | +50.57% |
| 2022-12-31 | $-3.76 Million | $838.39K | -0.223x | +14.85% |
| 2021-12-31 | $-1.03 Million | $271.05K | -0.262x | -112.82% |
| 2020-12-31 | $700.92K | $1.43 Million | 2.045x | +1273.33% |
| 2019-12-31 | $4.75 Million | $707.55K | 0.149x | -7.51% |
| 2018-12-31 | $18.06 Million | $2.91 Million | 0.161x | +0.03% |
| 2017-12-31 | $13.96 Million | $2.25 Million | 0.161x | +150.02% |
| 2016-12-31 | $15.78 Million | $1.02 Million | 0.064x | +102.99% |
| 2015-12-31 | $15.19 Million | $481.50K | 0.032x | -76.07% |
| 2014-12-31 | $10.64 Million | $1.41 Million | 0.132x | -74.65% |
| 2013-12-31 | $1.93 Million | $1.01 Million | 0.523x | +240.89% |
| 2012-12-31 | $273.21K | $-101.36K | -0.371x | -292.61% |
| 2011-12-31 | $318.85K | $61.41K | 0.193x | -70.48% |
| 2010-12-31 | $477.40K | $311.54K | 0.653x | +258.29% |
| 2009-12-31 | $607.19K | $-250.32K | -0.412x | -234.89% |
| 2008-12-31 | $-519.63K | $-158.81K | 0.306x | -60.11% |
| 2007-12-31 | $918.18K | $703.44K | 0.766x | +542.22% |
| 2006-12-31 | $1.15 Million | $-198.91K | -0.173x | -97.27% |
| 2005-12-31 | $1.21 Million | $-106.50K | -0.088x | +70.37% |
| 2004-12-31 | $1.24 Million | $-366.33K | -0.296x | -88.71% |
| 2003-12-31 | $1.21 Million | $-189.97K | -0.157x | -119.52% |
| 2002-12-31 | $913.84K | $735.17K | 0.804x | +409.27% |
| 2001-12-31 | $998.23K | $-259.66K | -0.260x | -308.88% |
| 2000-12-31 | $833.52K | $103.80K | 0.125x | +131.13% |
| 1999-12-31 | $500.00K | $-200.00K | -0.400x | -300.00% |
| 1998-12-31 | $500.00K | $100.00K | 0.200x | +200.00% |
| 1997-12-31 | $500.00K | $-100.00K | -0.200x | -- |